Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of oral Dehydroepiandrosterone
(DHEA) 50mg daily, for 12 months in naturally menopausal women with low libido who are not
receiving systemic oestrogen or oestrogen- progestin therapy.
Efficacy measures for the present study are effects on sexual function, wellbeing and
menopausal symptoms. Safety measures will include endometrial assessment by transvaginal
ultrasound (TVU), vital signs, lipid profiles, general electrolytes, effects on glucose
metabolism and reports of adverse events.